3SOF

My AVZA is looking like another possible jump...here.  Still holding

Just posting this again so it doenst get lost in all the shuffle of requests, if you could take a look at PMED i would greatly appreciated it. I posted it yesterday but you didnt have a chance to check it out.

Quote from: David Randolph on February 09, 2007, 12:22:20 PM

QuoteWow. If you are comparing this to SYX back in the day, then this should be a good point to buy in. Despite the big run up today, in your opinion David, would this still work to buy in now? I know you like to buy when you buy and sell when you sell and not time the thing but I was just curious. Thanks for your time on this one.

I compared the chart, fundamentals aren't so attractive, but still attractive. I don't know if you remember lancefur, but I was losing 15% on SYX due to poor short term timing, because I bought right after a similar gap up as you see on ZONS.

Now I'm ahead by 90% on SYX, due to having strong hands for good stocks.

Good luck

I do remember that as I was in the same boat and still sailing that boat with strong winds in my sail in my strong boat. I will try and buy into the mid point today if I can and see where this takes me. Thanks for the analysis as ususal.

Quote from: esn on February 09, 2007, 12:21:26 PM
Accuray (ARAY) went public yesterday. They make robotic radiosurgery equipment. If it follows  the pattern of ISRG (Intuitive Surgical) which made robotic surgery device, this could be a could stock to consider in the main portfoliol.

I dislike recent IPO stocks because companies have the bad habit (or necessity) of diluting shareholder's value right after being publicly traded. I've studied dozens of those stocks. They sell a small piece of the company to make the IPO price attractive and then dump newly issued shares on the way down.

I'm not saying that's the case with ARAY, though, I know nothing about the company.

Technically there's no analysis one can make with a two days chart.

Fundamentally the market cap is about $680 M, so it is above our limit, as you can read on the 3 SOF Portfolio FAQ

The company sold $80 M over the last four quarters, so the revenue multiple is 8.5, which is high. It lost $20 M over those last four quarters.

As I've said, I generally avoid recent IPO stocks, but I can be wrong on this one, it is kind of a gamble to me, good luck

TRT...don't think you have analized their earnings...but to me it looks good and undervalued...and has little debt.

Technically it's in danger of a black candle  :Pafter the gap up...but it it recovers this afternoon it could turn into a nice white candle.   Overall  market not helping.

Quote from: runner2847 on February 09, 2007, 12:58:19 PM
Just posting this again so it doenst get lost in all the shuffle of requests, if you could take a look at PMED i would greatly appreciated it. I posted it yesterday but you didnt have a chance to check it out.

Ok, lets take a look at PMED.OB.

Technically this is a typical penny stock rally. The stock rose what, 700% on Wednesday, then it opened with a gap up on Thursday and now is pulling back.

Fundamentally:

- Market cap is about $5 M. Develops, manufactures, sources, markets and sells ophthalmic surgical and diagnostic instrumentation and related accessories, including disposable products.
- Balance sheet is weak but I expected worse. $2.66 M in long term debt. Total equity is negative by $1.9 M
- Revenue trend is negative over the years, with revenues declining from $7.9 M in 2001 to about $2.1 M expected for 2006
- The company has been losing money every quarter, but not much, at least not much when compared to most biotech stocks.

Let's check the news that made it move so much on Wednesday:

• Paradigm Medical Receives FDA Approval for New-Generation Ultrasound Devices
Business Wire (Wed, Feb 7)

• Paradigm Medical Industries, Inc. CEO Featured in Exclusive WallSt.net Interview
PR Newswire (Fri 7:00am)

Ok, I think the first press release, despite not providing details, is powerful enough to take PMED.OB higher than current levels (because the market cap is still just $5 M), perhaps it will even double from here.

But the company will probably use the rally to unload shares to the public due to short term liquidity needs.

So, my take is PMED will have another bull leg and I would take profits then and wait for real revenue numbers out of the new products they're selling.

Good luck

Dave can you check out JADE...they are trying to get 100 stores in China before the olympic games and EPS growing fast.  Should get some PR because the products will be featured in gift bags for the grammys. PE is kind of high but considering there growth it may be cheap. I would like your take, thanks!

Recent News
LJ Intl Lorenzo Brand selected as a contributor to stars' gift bags at 2007 grammy awards

LJ International's ENZO Retail Unit Exceeds 2006 Goal for Store Count and Meets Fourth Quarter Goal for Positive EBITDA

Thanks a lot Dave. I ll hold PMED and wait for the next move. Hopefully we will get some additional pr's to the one from tuesday and this morning.

Quote from: nica33 on February 09, 2007, 10:03:37 AM
Hi David.  CECE, I asked about this one yesterday. Thanks

I made the following analysis on CECE in January the 22nd, 2007:

«CECE 3 minute look:

http://video.google.com/googleplayer.swf?docId=4059635027639177654&hl=en

At first sight CECE is a great stock to own, with both technicals and fundamentals pointing north. I'll consider it for a deeper study and perhaps a longer term investment.

It might pullback some though (and that would present a nice buying opportunity), as it is facing a medium term resistance around $13.»

And I should have bought the stock, as it is trading at $15 now.

Over some recent news I get the following:

«Phillip DeZwirek, Chairman and CEO of CECO stated, "CECO's bookings in 2006 increased 125% from $89 million in 2005 to $200 million in 2006. We also ended 2006 with a record back-log of approximately $100 million, up 245% year over year. After enjoying a record year in 2006, we are extremely pleased to begin the new year with a record order that will carry last year's momentum through 2007."»

Yep, no doubt CECE looks like a great long term investment. Still cheap here, growth is astounding.

CORI
Mk Cap: $119k million
BRIEF: For the six months ended 30 June 2006, Corillian Corporation's revenues rose 23% to $28.9M. Net Loss totaled $2.4M vs an income of $2.8M. Revenues reflect an increase in sales due to completion of license and implementation project . Net loss reflects an increase in salaries, commissions, marketing expenses, stock based compensation expense, higher research & development expenses and an increase in general & administrative expenses

Making a nice come-back move today .. overall trend seems up & this is one of Motley Fool's "Best Under $10"  FWIW 

Seems like CORI past it prime.
Majority of the revenue last year due to the Banking regulation and push to implement strong authentication solutions by end of 2006. They may have licensing revenue from existing customers but not likely to expand market share.

Quote from: tocitygirl on February 09, 2007, 10:19:22 AM
Hi david,

What are your thoughts on Aens.ob?

Hi tocitygirl, it's such a pity that you're not a Premium member anymore, but I understand, you mostly play penny stocks, right?

Anyway, let's see what we have for AENS.OB. Technically the medium and long term trend is decisively bearish as you can see on the chart below.

Fundamentally:

- Market cap is about $52 M. Engaged in the development of greenfield sites, including constructing, owning and operating fuel-grade ethanol plants.
- Balance sheet is ... well, they still got plenty of cash, about $9 M and just $166 K in liabilities. Total equity is $10 M
- Revenues were zero since inception
- Lost $1.09 M in Q3, probably it is starting to do something ...

Well, you know, this stock is in one of the groups that I refuse to look at (as you can read on the 3 SOF Portfolio FAQ), which are biotechnology, alternative energy and mining companies without any operations. They could only be seen as asset plays, at least for now, and I dislike asset plays because I don't have the tools to value the assets.

I don't have an opinion on the stock. Good luck

Quote from: prodigykid6 on February 09, 2007, 01:22:30 PM
Dave can you check out JADE...they are trying to get 100 stores in China before the olympic games and EPS growing fast.  Should get some PR because the products will be featured in gift bags for the grammys. PE is kind of high but considering there growth it may be cheap. I would like your take, thanks!

Recent News
LJ Intl Lorenzo Brand selected as a contributor to stars' gift bags at 2007 grammy awards

LJ International's ENZO Retail Unit Exceeds 2006 Goal for Store Count and Meets Fourth Quarter Goal for Positive EBITDA

I already studied JADE, look at the Stocks Covered List under "J".

JADE is a great stock, I should have bought it:

«

Quote from: nica33 on January 22, 2007, 10:53:18 AM
Hi David!!  What about JADE ??

I covered JADE a while back, it looked like a great stock, both from a technical and fundamental standpoint. You have that video here:

JADE 3 minute look:

http://video.google.com/googleplayer.swf?docId=4903260769825372173&hl=en

Great stock, looks kind of extended now, up about 50% over the last month or so, but perhaps there's still upside here. I'll have a further look, JADE is a good candidate, thanks nica33 »

I said nica33 for her to buy on the recent dip, I hope she did that, what a run!

Hi David - Sorry to post again, but I wasn't sure if it got overlooked...could you check out BULK?

Thanks!

Any thoughts on SFLY?